SORT BY

FILTER BY

also on other fortune lists

company facts

g500 stats

Global 500

Courtesy of Cardinal Health

34

Cardinal Health

CAH

U.S.

A distributor of pharmaceutical and medical products, Cardinal saw a 7% jump in sales. While business was brisk, weak pricing of generic drugs and the loss of a contract with Safeway led to a 10% loss in profits in 2017. Like its competitors, Cardinal has come under fire—and faces a bevy of lawsuits—for its alleged role in the nation’s opioid epidemic.

Looking for leads, investment insights, or competitive intelligence?

CEO

Michael C. Kaufmann

Sector

Wholesalers

Industry

Wholesalers: Health Care

HQ Location

Dublin, Ohio

Years on Global 500 List

21

Employees

40,400

Figures are for fiscal year ended June 30, 2017.
Key Financials (Last Fiscal Year)
($ Millions)% change
Revenues ($M)$129,9766.9%
Profits ($M)$1,288.0-9.7%
Assets ($M)$40,112
Total Stockholder Equity ($M)$6,808
Profit Ratios
Profit as % of Revenues1.0%
Profits as % of Assets3.2%
Profits as % of Stockholder Equity18.9%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Cardinal Health

The Justice Department Is Getting In on the War on Opioids

Attorney General Jeff Sessions announced a "statement of intent" to prop up suits against opioid makers and distributors.

Read More →
Amazon, Berkshire Hathaway and J.P. Morgan Are Forming a Non-Profit Health Care Venture

Sparking a selloff in the shares of a host of health care-related companies.

Read More →
Bluegonegone: China's bike-sharing bubble goes bust

The special Sino Saturday edition of CEO Daily.

Read More →